Department of Health and Human Services closed grants
1,832 federal funding opportunities from Department of Health and Human Services (HHS) that have closed, as they were listed on Grants.gov, newest close first (1,401–1,500 of 1,832, page 15 of 19).
HHS overviewPage 1Page 2Page 3Page 4Page 5Page 6Page 7Page 8Page 9Page 10Page 11Page 12Page 13Page 14Page 16Page 17Page 18Page 19
- The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)
- Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
- Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Limited Existing Geographic Service Areas
- HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
- Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
- Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
- Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
- Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
- Field Initiated Projects Program (Development)
- Field Initiated Projects Program (Research)
- State Offices of Rural Health Coordination and Development Program (SORHCDP)
- National Rural Health Information Clearinghouse Program
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
- Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
- Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
- Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
- BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
- Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
- Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
- Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
- NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31)
- NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed)
- Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
- Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed)
- Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)
- Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required)
- Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required)
- HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
- Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
- Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
- NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials)
- Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed)
- Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed)
- Halting Tuberculosis (TB) Transmission (R01 Clinical Trial Optional)
- Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)
- Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional)
- Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
- Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (U24 Clinical Trial Not Allowed)
- Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
- Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trials Not Allowed)
- Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
- KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)
- NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00)
- Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center (U24 Clinical Trials Not Allowed)
- SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional)
- STTR Solutions to Enable Population Genomic Screening (R41/R42 Clinical Trial Optional)
- Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional)
- Population Genomic Screening in Primary Care Coordinating Center(U01 -Clinical Trials Optional)
- Population Genomic Screening in Primary Care Cooperative Agreement (U01 - Clinical Trial Required)
- Advanced Rehabilitation Research Training (ARRT) Program - Employment
- Advanced Rehabilitation Research Training (ARRT) Program - Health and Function
- Advanced Rehabilitation Research Training (ARRT) Program - Community Living and Participation
- Advanced Rehabilitation Research Training (ARRT) Program - Disability Policy Research
- Novel Preclinical Models of NeuroHIV in the cART Era (R61/R33 - Clinical Trial Not Allowed)
- Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)
- Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional)
- Fiscal Year 2025 Health Center Controlled Network (HCCN) Cooperative Agreements
- Rigorously Evaluating Primary Prevention Strategies for Intimate Partner Violence and Sexual Violence
- Evaluate STEADI-based Fall Prevention in Assisted Living Facilities
- Formative Research of Community-led Primary Prevention Approaches to Address Elevated Risk of Intimate Partner Violence & Sexual Violence
- Research Grants for Preventing Violence and Violence Related Injury (R01)
- Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse and Problematic Sexual Behavior among Youth
- Environmental Health Specialists Network (EHS-Net) Practice-based Research to Improve Food Safety
- Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populations Disproportionately Affected by Overdose
- Effectiveness Research to Prevent Polysubstance-Impaired Driving
- Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth
- Research Grants to Rigorously Evaluate Innovative and Promising Strategies to Prevent Firearm-Related Violence and Injuries
- Rigorous Evaluation of Community- and Societal-Level Primary Prevention Approaches to Prevent Adverse Childhood Experiences (ACEs): Expanding the Best Available Evidence
- NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)
- NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
- NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)
- NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
- Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
- NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional)
- NIOSH Centers for Agricultural Safety and Health
- Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)
- NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
- Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use Disorder (StUD) Enriched for Vulnerable Phenotype (U01 Clinical Trial Required)
- Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
- Alcohol Health Services Research (R34 Clinical Trial Optional)
- Alcohol Health Services Research (R01 Clinical Trial Optional)
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
- Dissemination and Implementation Research in Communication Disorders Conference (U13 Clinical Trial Not Allowed)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
- Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
- HIV Prevention and Alcohol (R01 Clinical Trials Optional)
Same-day alerts, matched to you
The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31. One free trial per customer.
Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.
Start 30 days free →Just want the free weekly list?
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.
No spam, ever. Privacy